Back to top
more

IDEXX Laboratories (IDXX)

(Delayed Data from NSDQ)

$476.27 USD

476.27
490,369

+2.99 (0.63%)

Updated Oct 11, 2024 04:00 PM ET

After-Market: $476.27 0.00 (0.00%) 5:30 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (101 out of 251)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Tirthankar Chakraborty headshot

5 Top-Performing S&P 500 Stocks of Q1

We have highlighted five S&P 500 stocks that have dished out double-digit returns in Q1 and remained undisturbed by higher bouts of volatility

    Why Should You Add IDEXX (IDXX) Stock to Your Portfolio?

    IDEXX (IDXX) might gain from the commercial launch of Catalyst SDMA Test in North America. As a result, its point-of-care customers can add SDMA as an essential element to the routine chemistry panel.

      IDEXX Laboratories Gains on Solid Prospects & CAG Business

      IDEXX Laboratories (IDXX) continues to boost investor confidence in strong companion animal business along with attractive global prospects.

        Here's Why You Should Invest in IDEXX Laboratories (IDXX) Now

        IDEXX Laboratories (IDXX) continues to boost investor confidence on strong companion animal business along with growth across all segments.

          Zacks.com featured highlights include: Lululemon, Exelixis, IDEXX, Teradyne and Pioneer Natural

          Zacks.com featured highlights include: Lululemon, Exelixis, IDEXX, Teradyne and Pioneer Natural

            Tirthankar Chakraborty headshot

            5 of the Best Efficient Stocks for Your Portfolio

            Companies with a favorable efficiency level are expected to provide impressive returns as efficiency is believed to be positively correlated with price performance.

              Second Sight (EYES) Catches Eye: Stock Jumps 12.7%

              Second Sight (EYES) saw a big move last session, as its shares jumped nearly 13% on the day, amid huge volumes.

                IDEXX Laboratories Strong on CAG Business Amid Currency Woes

                IDEXX's (IDXX) innovation-based global strategy is leading to growth at CAG Diagnostics.

                  IDEXX Laboratories (IDXX) Beats on Q4 Earnings and Revenues

                  IDEXX (IDXX) rides high on strength in CAG business in Q4. A raised guidance buoys optimism.

                    IDEXX Laboratories (IDXX) Beats on Q4 Revenues, View Up

                    IDEXX Laboratories (IDXX) gains on solid contributions from Companion Animal Group business in Q4.

                      Medical Device Stocks Earnings Due on Feb 1: BSX, BAX & More

                      As part of the amended tax policy, corporate tax rates are lowered to 21% from 35%, offering a huge relief to medical device giants.

                        Can IDEXX (IDXX) Post a Beat in Q4 Earnings on CAG Strength?

                        IDEXX Laboratories (IDXX) is poised to gain from strength in CAG Diagnostics business in Q4.

                          IDEXX Launches Catalyst SDMA for Veterinary Renal Disorder

                          IDEXX Laboratories (IDXX) already puts its Catalyst SDMA Test to use for hundreds of medical practices across the United States.

                            5 Reasons Why You Should Buy Baxter (BAX) Stock Right Now

                            Baxter (BAX) has been gaining on the back of favorable developments in the regulatory front and product launches.

                              Intuitive Surgical Banks on da Vinci X, Forex Woes Remain

                              Intuitive Surgical's (ISRG) consistent efforts to boost da Vinci X platform is a positive. However, foreign exchange movements are impacting the company's results

                                6 MedTech Stocks Set to Crush the Market in 2018

                                Here we take a peek at six MedTech stocks that are expected to post stellar returns in 2018.

                                  Ecolab, Cargill and Techstars Launch Accelerator Program

                                  Ecolab (ECL) continues to focus on investment in key businesses and bolt-on acquisitions to gain market traction and boost profits.

                                    Here's Why You Should Invest in PetMed (PETS) Stock Now

                                    PetMed's (PETS) implements strategies to revitalize top line. It also offers a comprehensive portfolio.

                                      IDEXX Laboratories Banks on Global Prospects, CAG Strength

                                      IDEXX Laboratories (IDXX) rides on strength across all segments, especially CAG. Strong fundamentals buoy optimism.

                                        Ecolab Focuses on Pest Elimination, Acquires 3 Companies

                                        Ecolab (ECL) continues to focus on investment in key growth businesses and bolt-on acquisitions to gain market traction and boost profits and inorganic growth.

                                          Zacks.com highlights: Chemed, Baxter International, IDEXX Laboratories, Advanced Energy Industries and Pioneer Natural Resources

                                          Zacks.com highlights: Chemed, Baxter International, IDEXX Laboratories, Advanced Energy Industries and Pioneer Natural Resources

                                            Tirthankar Chakraborty headshot

                                            5 of the Most Efficient Stocks to Boost Your Portfolio

                                            Company with a favorable efficiency level generally provides impressive returns as it is believed to be positively correlated with the stock's price performance.

                                              Here's Why You Should Invest in Baxter (BAX) Stock Right Now

                                              Baxter has witnessed favorable tidings on the regulatory front. The company enjoys strong presence in foreign markets.

                                                Varian's Partners Penn Medicine, Proton Therapy in Focus

                                                Varian Medical's (VAR) solid prospects on the proton therapy space holds promise at the moment.

                                                  Stryker Gains Ground on MAKO Robotic Unit Amid Forex Woes

                                                  Solid performance by the MAKO robotic platform has been boosting Stryker's (SYK) revenues for long.